Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Jul 28, 2016 04:10 PM Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Jul 28, 2016 10:00 AM Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology
Jul 26, 2016 05:27 PM BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets
Jul 25, 2016 08:30 AM Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity
Jul 21, 2016 07:30 AM Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B
Jul 19, 2016 08:00 AM Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®
Jul 18, 2016 06:15 AM ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Women Living with HIV
Jul 13, 2016 08:00 AM Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis
Jul 12, 2016 04:04 PM Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
Jul 8, 2016 08:00 AM Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma
Jul 6, 2016 08:00 AM Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jul 6, 2016 08:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jul 5, 2016 11:34 AM Hercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy
Jul 1, 2016 05:30 PM BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc.
Jun 28, 2016 08:30 AM Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results
Jun 27, 2016 11:30 PM Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Jun 24, 2016 09:00 AM Pfizer Completes Acquisition of Anacor
Jun 23, 2016 04:00 PM Pfizer Declares 30-Cent Third-Quarter 2016 Dividend
Jun 21, 2016 10:00 AM Roger Ulrich Joins Board of Remedy Pharmaceuticals
Jun 21, 2016 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts
Jun 16, 2016 09:00 AM Help Pfizer Change The Future Of Healthy Aging
Jun 16, 2016 08:30 AM Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts
Jun 14, 2016 07:00 AM Shire to License PF-00547659 from Pfizer, Adding to Established and Leading Gastrointestinal Portfolio
Jun 13, 2016 07:15 AM Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity
Jun 12, 2016 05:15 AM Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Jun 11, 2016 11:00 AM Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2 Inhibitor, Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes
Jun 10, 2016 09:15 AM ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV
Jun 10, 2016 06:00 AM ICON Announces Service Agreement with Pfizer
Jun 9, 2016 07:30 AM Pro Golfer Jim Furyk Teams Up With Pfizer To Raise Awareness For Pneumococcal Pneumonia And The Importance Of Older Adult Vaccination
Jun 8, 2016 07:15 PM Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules for Approval
Jun 8, 2016 07:01 AM Pfizer Research Advances Body Of Evidence For Tofacitinib Citrate (XELJANZ®) Providing Clinicians With Additional Information For The Treatment Of Moderate to Severe RA
Jun 7, 2016 07:00 AM Pfizer Announces Positive Top-Line Results from Second Phase 3 Trial of Oral XELJANZ® (Tofacitinib Citrate) in Adults with Psoriatic Arthritis
Jun 6, 2016 09:00 AM ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
Jun 6, 2016 09:00 AM ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
Jun 6, 2016 08:00 AM Pfizer Presents Promising Data from Next Generation ALK/ROS1 Inhibitor in Advanced Non-Small Cell Lung Cancer
Jun 4, 2016 08:00 AM Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor
May 31, 2016 07:05 PM Pfizer Prices $5.0 Billion Debt Offering
May 31, 2016 09:00 AM BioRap Technologies to Enter Strategic Collaboration With Pfizer Inc. to Research and Develop Novel Immunomodulators
May 31, 2016 09:00 AM ViiV Healthcare and the International Association of Providers of AIDS Care (IAPAC) to Collaborate on Fast-Track Cities
May 26, 2016 10:38 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 23, 2016 07:00 AM CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP
May 20, 2016 08:00 AM Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)
May 20, 2016 06:00 AM On BizWireTV: Streaming Service Finds Television and Climate Change on the Radar
May 19, 2016 08:30 AM Hospira Launches LifeCare PCA® 7.0 Infusion System, First PCA Pump That Integrates with the Electronic Medical Record
May 19, 2016 06:30 AM Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therapeutic Levels of Factor IX Expression
May 18, 2016 05:30 PM Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:30 PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:00 PM Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
May 17, 2016 08:00 AM Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)
May 16, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Back to PFE Stock Lookup